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Based on theoretical models scaffold 13 was predicted to self assemble through 
intermolecular hydrogen bonds.  The synthesis of scaffold 13 (napthylalanine-Pro4(2S4R)-
Pro4(2R4S)-Pro4(2S4R)-Pro4(2R4S)) was successfully synthesized using standard Fmoc Solid 
Phase Peptide Synthesis.  Connectivity was confirmed through full structural characterization 
(1H NMR, COSY, HMQC, HMBC, ROESY).  Scaffold 13 was probed for its ability to self-
assemble in DMSOd6 in the presence of 0.2 % TFA (13 mM – 4 mM).  Our hypothesis for self-
assembly of scaffold 13 was not supported under any of the conditions explored.  ROESY 
correlations failed to indicate self-assembly between interacting scaffolds and a variable 
temperature (25 to 80 °C) NMR study at three separate concentrations (13 mM, 4mM, 1 mM) 
also failed to provide evidence of self-assembly.  
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1.0  NATURE AS INSPIRATION 
The natural world has long provided inspiration for scientists and scholars.  With a subset of 
molecules, nature routinely constructs large, intricate, functional structures, used in virtually 
every significant biological process.  Nature effortlessly builds an enormous and diverse array of 
highly efficient nanoscale machines.  Biological molecular machines can be as simple as the 
heme containing proteins myoglobin and hemoglobin which shuttle molecular oxygen and 
carbon dioxide to and from living cells or more complex such as highly specific proteases, 
nucleases, and kinases designed to enable the efficient chemical modification of numerous 
biomolecules1.  Even more complicated molecular machines can be identified, such as the 
ribosome, responsible for translation of messenger RNA into proteins and microtubles, which 
play a crucial role in cell division1.  The level of sophistication with which nature assembles 
these nano-scale devices provides an enormous source of inspiration.  She challenges us to 
mimic her ability to control structure at the molecular level in a quest to produce ever more 
intricate materials and devices.  
Many biological processes are governed by selective interactions between discrete 
molecules.  Once a protein is assembled through biosynthesis, it naturally folds under 
physiological conditions into its functional form in a process known as protein folding2.  It is 
believed that unfolded proteins do not simply fold by sampling all possible conformations 
randomly until the lowest free energy is encountered.  This is not feasible based on a practical 
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time scale since peptide chains can adopt a vast number of conformations.  It is believed that 
protein folding is largely ordered although it is not necessarily a direct pathway.  Some proteins 
fold through the assistance of accessory proteins, such as molecular chaperones which can 
prevent improper folding and aggregation of proteins. Hydrophobic forces largely drive protein 
folding in which hydrophobic side chains are often hidden from the aqueous environment while 
the hydrophilic groups are exposed3.  Although much progress has been made in understanding 
the underlying mechanism of protein folding, we still do not fully understand how or why 
proteins adopt their active tertiary conformations.  Chemists have made considerable efforts in 
designing non-natural peptides that emulate the highly evolved characteristics of proteins.  
 
1.1 NANOTECHNOLOGY 
Nanotechnology is concerned with the precise control over the placement of atoms in three 
dimensional space, especially with respect to the production of useful nanoscale devices.   
Although the field remains in its infancy, nanotechnology ultimately brings with it the promise 
of radical new technologies through precise, rational control over structure.  
Two major strategies have been employed for the construction of nanoscale structures.  
The first is a top-down approach in which the final structure is produced by stripping excess 
material.  A common top-down approach involves photolithographic patterning techniques using 
optical sources.  A key advantage of the top-down approach is that no assembly step is needed. 
Optical lithography is a relatively mature field with techniques capable of reaching dimensions 
just below 100 nanometers4.  However, the disadvantages to this approach include physical and 
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economic costs that limit the use of this technology in the construction of smaller, more intricate 
structures.  To the contrary, the bottom-up approach assembles nanostructures molecule by 
molecule, even atom by atom4.  The bottom up approach requires a set of building blocks that 
can be assembled to create larger, more complex structures.  The shape of the parent structure is 
dependent on the nature and sequence of the building blocks.  Nature uses this approach in the 
construction of peptides and nucleic acids.  Polymer chemistry utilizes this approach in the 
construction of polymeric materials with unique bulk properties.  The ultimate limitations of this 
approach are the building blocks themselves.  Although both approaches are useful, the bottom 
up approach is likely to become an important component of nano-material manufacture since it 
provides the greatest control of placement of atoms and molecules4.  With the bottom-up 
approach as a viable option to precisely control molecular architecture, chemists are able to 
synthesize molecules and assemble them in such a way as to produce useful nanoscale devices. 
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1.2 UNNATURAL MONOMERS 
Numerous unnatural monomers have been designed which can be assembled into larger 
oligomeric structures.  Oligomers constructed from these monomers that fold into a well defined 
secondary structures, foldamers, are governed by weak, usually intramolecular noncovalent 
interactions that stabilize the resulting secondary and tertiary structures of these compounds in 
solution5.  Typically oligomers are assembled through single bonds between monomers such as 
β-amino acids6, 7, sulfonamidopeptides8, oliopyrrolinones9, oligoanthranilamides10, oligoureas11-
15, phenylacetylene oligomers16, 17, and vinylogous amino acids18.   
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Figure 1.  Unnatural Amino Acids  
One successful example in the research of synthetic foldamers has been the development 
of U-turns to control the secondary structure in triureas that serve as functional mimics of their 
biological counterparts, the β-turn.  Intramolecularly hydrogen bonded ten-membered ring 
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conformations in dilute chloroform solutions have been shown to control the structure of an 
oligourea backbone (Figure 2)15.  This work has been extended to a variety of acylic diureas in 
which hydrogen bonding creates conformationally well-defined structures 11, 12, 14, 19, 20, however, 
the majority of examples which have demonstrated secondary structure have been in aprotic 
organic solvents.  
 
Figure 2.  Intramolecular hydrogen bonded rings formed in triureas.  
 
Another example involving the use of intramolecular hydrogen bonding to control 
conformation utilizes anthranilamide oligomers10.   Intramolecular hydrogen bonding in addition 
to the trans requirement of the amide bond is responsible for the preferred conformation (Figure 
3).  The x-ray structure exhibits a helical arrangement of the rings stabilized by intramolecular 
hydrogen bonds (NHa···N, 2.20 and 2.21 Å); NHa···OC, 1.82 and 2.02 Å).  The terminal 
anthranilamide rings are 5.41 Å apart.  Supporting evidence of the intramolecularly hydrogen 
bonded network was provided by a variable temperature NMR experiment (from -40 to 40 °C) in 
which shifting of the amide-NH resonances in a 10 mM solution of the compound in 20% 
DMSOd6/80% CDCl3 was assessed.  The intramolecular hydrogen bonded amide protons 
exhibited a small variation with temperature (2.9 x 10-3 and 1.1 x 10-3 ppm) in the polar solvent 
system.    
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Figure 3. Intramolecular hydrogen bonded anthranilamide oligomer (left).  X-ray structure (right).  
 
The control of specific functionality in space leads to numerous potential applications.  
Among these is the possibility for the generation of species capable of binding to small 
molecules21.  Dibenzodiazocines are rigid species that are able to orient their functional groups, 
such as carboxylic acids, at an angle of approximately 120° with respect to one another, allowing 
these molecules to serve as synthetic receptors22.   These functional groups are well-arranged for 
binding several same guests such as 9-ethyladenine and biotin methyl ester through multiple 
hydrogen bonds.  
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Figure 4. Orderly functional group dyads as synthetic hosts 
 
Dibenzodiazocines position the carboxylic acids in the required configuration as a direct 
consequence of the rigid nature of their backbone.  The barrier for the aryl-aryl bond rotation for 
host (R=COOH) was determined to be 15.0 kcal/mol in THF-d8 or methanol-d4.   The 
dibenzodiazocines host (R=COOH) binds to 9-ethyladenine in THF-d8 quite strongly 
demonstrating Ka of 140 M-1 22.  
Others have achieved well-defined structures through the utilization of pi-stacking 
between subunits, rigidification to minimize conformational degrees of freedom, donor-acceptor 
interactions, and destabilization of unwanted conformations10.  Although significant progress has 
been achieved in this area, there remain numerous problems with some of the previously 
described building blocks: solubility problems, long coupling times, uncertainty with regard to 
the oligomeric folding unique to the building blocks, and high degree of symmetry.   
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1.3 BIS-AMINO ACIDS 
Our research group has designed an approach for the synthesis of molecular scaffolds that 
possess well-defined structures in aqueous solution.  The scaffolds are assembled from 
monomers through solid phase peptide synthesis.  Following synthesis, the scaffolds are 
rigidified through the formation of a pair of bonds between the cyclic monomers.  Elimination of 
multiple degrees of freedom from within each scaffold ensures that the synthetic structures are 
incapable of folding, thus eliminating difficulties associated with the prediction of the folded 
structures in solution.  These compounds adopt fixed and predictable conformations that are 
readily modeled computationally.  By varying the monomers used to construct each scaffold, a 
diverse array of molecular architectures can be obtained (Figure 5)  
 
 
Figure 5. Cartoon of monomers that can be incorporated into an array of structurally defined scaffolds. 
 
 9 
Boc
N CO2H
FmocHN
CO2Me
Boc
N CO2H
FmocHN
CO2Me
Boc
N CO2H
FmocHN
CO2Me
Boc
N CO2H
FmocHN
CO2Me
Pro4(2R,4S)Pro4(2R,4R)Pro4(2S,4R)Pro4(2S,4S)
Boc
N CO2H
FmocHN
CO2C3H3F4
Boc
N CO2H
FmocHN
CO2C3H3F4
Boc
N CO2H
FmocHN
CO2C3H3F4
Boc
N CO2H
FmocHN
CO2C3H3F4
Pip5(2S,5S) Pip5(2R,5R)Pip5(2S,5R) Pip5(2R,5S)
Boc
N CO2H
NHFmocF4C3H3O2C
Boc
N CO2H
NHFmocF4C3H3O2C
Pip4(2S,4S) Pip4(2S,4R)
N
O
HO
Cbz
H
H
O OMe
NHPhF
Hin(2S,4R,7R,9R)
 
Figure 6. Library of Monomers 
 
Our bis-amino acid monomers23-27 (Figure 6) are derived from inexpensive, commercially 
available starting materials.  The synthesis of our Pro4(2S,4S) monomer starts with Cbz-
protection of 4-hydroxyproline to provide 2  (Scheme 1).  Oxidation to 3 with Jones reagent, and 
subsequent protection of the carboxylic acid as its corresponding t-butylester provided the fully 
protected 4-ketoproline intermediate (4).  Application of the Bucherer–Bergs reaction at this 
stage allowed for access to a mixture of two diastereotopic hydantoins (5) that could be 
conveniently separated by column chromatography.  Following global Boc activation to provide 
6, base hydrolysis of the urea revealed the latent amino acid 7.  The resulting primary amine was 
Fmoc protected to provide (8) and the acid converted to its corresponding methylester (9) with 
TMS-diazomethane.  Removal of the t-butylester with TFA in dichloromethane proceeded to 
yield 10, and allowed for the ultimate Cbz to Boc protecting group exchange, and completion of 
the Pro4(2S,4S)  monomer (11) synthesis.  Syntheses of the other monomers are analogous to 
that described in (Scheme 1).  
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Scheme 1. Synthesis of Pro4(2S,4S) monomer 
 
Although the Pro4 monomer syntheses were developed previously, we were able to 
introduce a more reliable method for Fmoc protection in which 9-Fluorenylmethyl succinimide 
carbonate carbonyl (Fmoc-OSu)28 was used in place of 9-Fluorenylmethyl chloroformate (Fmoc-
Cl) to protect the primary amine.  Fmoc-OSu proved to be a superior reagent, providing the 
protected product in good yield and high purity, in addition the reagent allowed for reduced 
reaction setup time and cost, and was easily amenable to scale up without compromising product 
yield.  
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1.4 BIS-AMINO ACIDS INCORPORATION INTO RIGID A SCAFFOLD 
Molecular scaffolds derived from our monomers are assembled using standard Fmoc solid phase 
peptide synthesis29.  An advantage of solid phase synthesis is that reactions can be driven to 
>99% completion in the presence of excess reagents which can be easily removed at the end of 
the reaction by simple filtration.  Our scaffolds are generally synthesized on a polystyrene 
polymeric support using standard Fmoc peptide synthesis protocols.  In order to couple the first 
residue onto the alcohol which is immobilized onto the solid support, 1-(Mesitylene-2-sulfonyl)-
3-nitro-1H-1,2,4-triazole (MSNT) is used to activate the amino acid.  Each building block 
thereafter is coupled to the next using O-(7-Azabenzotriazol-1-yl)-N,N,N',N'-
tetramethyluroniumhexafluorophosphate (HATU) activation (Scheme 2).  Fmoc removal is 
achieved by treatment with 20% piperidine in DMF for 30 min.  Fmoc deprotections were 
quantified by measuring the UV absorbance of the dibenzylfulvene-piperidine adduct at 301 nM 
(ε = 7800 cm-1mol-1).  In order to monitor our scaffolds by HPLC following cleavage from the 
resin, a UV chromophore such as 1-naphthylalanine or tyrosine  is incorporated early in the 
synthesis.   
 
OH
1.) MSNT, MeIm, 
      Fmoc-Tyrosine
2.) 20% Piperdine/DMF
O
O
NH2
1.) Pro 4(2S,4R), HATU, DIPEA
2.) 20% Piperidine/DMF
3.) Pro 4(2R,4S), HATU, DIPEA
4.) 20% Piperidine/DMF
5.) Pro 4(2R,4S), HATU, DIPEA
6.) Acetic Anhydride, DIPEA
7.) 20% Piperdine/DMF
O
O H
N N
Boc
MeO2C
O
NBoc
CO2Me
HN
O
BocN
CO2Me
NH
O
1.) 1:1 TFA:DCM
2.) 10% DIPEA in DCM
TFMSA, TFA, 
scavengers
PGO
PGO
O
O H
N N
H
MeO2C
O
NH
CO2MeHN
O
HN
CO2Me
OPGO
H
N
NH
O
H
N
O
HO
O H
N N
H
MeO2C
O
NH
CO2MeHN
O
HN
CO2Me
OHO
H
N
NH
O  
Scheme 2. General synthesis of bis-amino acid scaffold 
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Once the scaffold is synthesized and cleaved from the resin, multiple diketopiperazines 
are formed along the scaffold backbone using a solution of 20% piperidine in NMP (Scheme 3).  
This affords a rigid backbone that provides a novel approach to well-defined molecules that can 
be synthesized on a relatively short time scale.  The completed scaffolds were purified by 
preparative reverse phase HPLC on C18. 
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Scheme 3. Diketopiperazine Closure of a Tetramer 
 
The purified materials were subjected to analytical HPLC-MS to assess both molecular 
weight and purity.  From a small set of 10 building blocks, there are 104 (10,000) different 
possible tetramer structures that could be constructed, allowing for an extremely diverse array of 
rigid structures.  Our long-term goal utilizing bis-amino acid monomers is to control overall 
shape and size of scaffolds that would exhibit the required surface features to accomplish a 
specific biological task in order to produce useful catalysts, sensors, mini-proteins and various 
molecular machines.  
 13 
1.5 MICROWAVE ASSISTED DIKETOPIPERAZINE CLOSURE 
Diketopiperazine formation has been the subject of several reviews30, 31.  Our initial DKP closure 
conditions employed an intramolecular aminolysis reaction between an amine and an ester 
catalyzed by 20% piperidine in dimethylformamide.  These conditions are quite reliable for 
producing our rigid scaffolds containing Pro4 monomers, however they are not ideal for several 
reasons.  The major concern under these basic conditions is that epimerization can occur32 and 
that these conditions cannot afford rigidified Pip5 scaffolds.   This led us to develop mild and 
general conditions to rigidify all scaffolds.   
Utilizing acid catalyzed conditions to close DKPs would potentially allow reaction 
mixtures to be heated in order to reduce reaction times without endangering the stereocenters. 
Microwave (MW) irradiation is an attractive approach over traditional heating for several 
reasons.  MW heating provides a more efficient means for heating a reaction mixture.  This 
technique has frequently been demonstrated to produce higher product yields in contrast to the 
same reaction being carried out under conventional heating.  Combining MW irradiation and an 
acid catalyst could offer an alternative for DKP formation and potentially would improve our 
approach to rigid scaffolds not only through decreased reaction times, but could allow for more 
demanding sequences to undergo DKP formation.   
Our initial studies were designed to determine if we could utilize acidic conditions in 
conjunction with microwave heating to close DKPs between Pro4 monomers (Scheme 4).  If the 
conditions indeed worked, we could determine the half-life of DKP closure.  We studied several 
solvents (NMP, DMF, o-Xylene), under MW irradiation at several temperatures (70°C, 100°C, 
130°C), and in the presence of one catalyst ( 80mM acetic acid, 80 mM benzoic acid, 50 mM 
triethylamine and 100mM acetic acid, and 50mM triethylamine and 60mM acetic acid). 
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Scheme 4. General DKP closure using acidic conditions 
 
The derivitized resin was heated at the desired temperature and duration inside a CEM 
Discover microwave.  This was repeated over a series of time points.  We assumed that this 
reaction obeys first order kinetics and a plot of ln I [I= area of starting material/ area of starting 
material + area of product (analyzed by HPLC)] against time t seems to support this assumption 
as it provides a linear fit to the observed data points.  From these data we were able to derive the 
half-life for this transformation given by the equation t1/2=ln 2/ k.   From Figure 7 a straight line 
of the data when ln I is plotted against time t suggests a half life of 35.4 minutes for the closure 
of one diketopiperazine under the conditions of 80 mM AcOD at 100 ° C in DMF.  We 
concluded that acidic conditions could effectively close one DKP between Pro4 monomers and 
drastically reduced reaction time from previous basic conditions.  
Half life for DKP closure: 80mM AcoD, 100 C in DMF
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Figure 7.  Half-life experiment of DKP closure. 
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Since the 20% piperidine in DMF was unable to close DKPs between Pip5 monomers we 
set out to extend the acidic condition to see if they could close DKPs between Pip5 monomers.  
The acidic conditions under microwave heating could close a DKP between Pip5 monomers, 
however, the reaction was extremely slow.  Sharad Gupta proceeded to develop second 
generation monomers (Figure 8) in which the methyl ester had been replaced with a 2,2,3,3-
tetrafluoropropyl (TFP) esters.  This allowed us to examine the effect of the improved leaving 
group in the TFP ester.  Indeed, scaffolds with the TFP ester demonstrated greatly accelerated 
DKP closure.   
N
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Figure 8.  Pro4 and Pip5 TFP ester monomers 
The reaction conditions 100mM AcOD, 50 mM TEA, 130° MW for 30 min were 
employed in closing five DKP between Pip5(2S5S) (TFP esters) a previously sluggish reaction 
containing Pip5 methyl ester building blocks, utilizing microwave irradiation (Figure 9). 
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Figure 9.  Second-generation monomers undergoing DKP formation 
The cleaved product was characterized by C18 reverse-phase HPLC (Figure 10) with 
mass spectrometry.  After 30 minutes the major peak was indicated by mass spectrometry to be 
the desires product.  Two smaller peaks correspond to intermediates that failed to close one 
DKP.  There was no evidence that epimerization occurred. 
 
Figure 10.  Unpurified reverse-phase C18 HPLC of Pip5 scaffold 
Recently our work was published33 and we are currently employing this new 
methodology to synthesize larger and more complex rigid oliogomers.   
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1.6 PREVIOUS WORK   
Utilizing the unique Computer Aided Nanostructure Design and Optimization (CANDO) 
software34, in conjunction with the molecular mechanics package of MOE35, we were able to 
predict the probable conformations for our rigid scaffolds.  This allowed us to first rapidly screen 
numerous interesting and unique structures using CANDO, and then synthesize the most 
interesting structures in the laboratory.  Two dimensional NMR spectroscopy techniques were 
routinely used to confirm that the solution structures of the molecular scaffolds synthesized in 
the lab correspond with the predicted structures, thus allowing constant evolution and refinement 
of CANDO.  Structure determination was achieved through analysis of the results provided by 
1H-1H Correlated Spectroscopy (COSY), 1H-13C (HMQC), long range 1H-13C (HMBC), and 
through-space 1H-1H (ROESY).  For the Pro4 building blocks, key structural information has 
been previously reported23, 24. It has been demonstrated the diketopiperazine between two Pro4 
building blocks forms a shallow boat conformation, in which the R1 substituent resides in a 
pseudo-equatorial position (Figure 11).  An envelope conformation is adopted by the five 
membered ring to avoid 1,3 diaxial strain between the carbonyl and amide proton.  To date no x-
ray crystal structures of our scaffolds have been obtained.  
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Figure 11.  Conformation of the Pro 4 monomer within a scaffold  
1.7 SELF ASSEMBLY THROUGH HYDROGEN BONDS 
Assembly of molecules through weak non-covalent interactions (i.e. hydrogen bonds) is a 
phenomena widespread in nature.  In a strand of double helical DNA, the base pairs of adenine 
and thymine, or guanine and cytosine form intermolecular hydrogen bonds that define and 
rigidify the helical structure of DNA.  Developing the ability to control tertiary structure through 
manipulation of hydrogen bonding, as nucleic acids and proteins are able to, has attracted much 
attention.  Hydrogen bonds are important because of the effects they have on the properties of 
compounds: boiling point, melting points, solubility, spectral absorption positions.  Hydrogen 
bonding is particularly attractive for the creation of self-assembled molecules because arrays of 
hydrogen-bond donor and acceptors can be utilized to induce self-assembly and because 
hydrogen bonds can be directional.      
 Hydrogen bonding can be detected in many ways.  One of the most valuable techniques 
for assessing these interactions is through is Infrared Spectroscopy (IR).  The IR frequencies of 
common hydrogen bond donor and acceptor, such as O-H or C=O are red shifted when the group 
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is hydrogen bonded.  For example, a free alcohol absorbs at ~3590-3650 cm-1, whereas a 
hydrogen bonded O-H group absorbs ~50-100 cm-1 lower frequency.  As seen in Figure 12 (b), a 
red shifted peak at 3430cm-1 corresponds to a hydrogen-bonded NH absorption in a N,N-bis(2-
cyanoethyl)-N’-methylurea19.  In the IR spectra (295 K) (a) at 10 mM the molecule exhibits 
modest self-association while at 50 mM (b) the molecule exhibits a substantial hydrogen-bonded 
NH peak.  
 
Figure 12.  IR spectra of Intramolecular Hydrogen Bonded Ureas. (a) 10 mM: 3481, 3430 cm-1 (weak) (b) 50 
mM: 3481, 3425 cm-1.   
 
NMR spectroscopy can also be utilized to detect hydrogen-bonded species.  Chemical 
shifts for hydrogen bonded amide protons and non-hydrogen bonded amide protons greatly differ 
due to the presence of the hydrogen bond.  In the presence of a hydrogen bond, shielding effects 
induced by the acceptor alter the amide proton chemical shift relative to non-hydrogen bonded 
amide protons.  Chemical shifts depend on the inverse third power of the distance between amide 
proton and hydrogen bond acceptor36.  As the temperature of the NMR sample is increased, 
thermal energy of the system increases resulting in an increase in the length of the hydrogen 
bond.  As the length of the hydrogen bond increases, shielding affects arising from the proximity 
of the hydrogen bond acceptor are dramatically decreased and thus the chemical shift of the 
amide proton is shifted downfield to a lesser extent.   
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A complementary experiment to variable temperature NMR is dilution NMR.  If a system 
does self-assemble, the aggregation state will depend on the concentration.  At a defined 
concentration the system will self-assemble, but as the concentration becomes increasingly 
dilute, the system becomes less likely to associate.  An example of this phenomenon 
demonstrated using the short peptide sequence in Figure 1337.  Figure 14 describes the 
concentration study on this molecule performed in CDCl3.  The chemical shift of the urea NH is 
shifted downfield ~0.2 ppm when self-assembled and as the concentration is decreased the urea 
NH is shifted upfield.  
 
Figure 13.  Dipeptidyl Urea 
 
 
Figure 14.  1H NMR shift of Urea NH at 25 °C in CDCl3. 
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Another useful NMR phenomenon for detecting self-assembly in solution is the proton magnetic 
resonance nuclear Overhauser enhancement (nOe).  Observation of an nOe of one hydrogen 
signal on irradiation of another indicates that those hydrogens are within 4 Å of one another.  
Therefore, if a molecule is interacting with itself, nOe’s should be observed from one scaffold to 
the second scaffold correlating protons in proximity.  An nOe experiment was used to confirm 
that the molecule in Figure 13 was indeed forming higher order structures in solution.  The solid 
arrows indicate the observed NOE’s37.  
 
 
Figure 15. NOE’s observed between dipeptidyl ureas. 
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2.0  BIS-AMINO ACIDS: AN APPROACH TOWARDS SELF ASSEMBLY  
The primary focus of my graduate research has been the synthesis of 13 (Scheme 5) and 
exploring its potential for self-assembly into higher order structures (dimers, trimers, tetramers, 
etc.).  This particular scaffold sequence (13) sparked interest because of its apparent potential for 
aggregation through hydrogen bonded networks.  Utilizing CANDO in conjunction with the 
molecular mechanics package MOE, we have been able to predict with reasonable certainty 
several probable conformations of 13.  The energy minimized structure of 13 provided by MOE 
revealed a pair of amide bonds with hydrogen bond donor and acceptor: 4HN and 5O, 2HN and 
3O which could potentially participate in the formation of four intermolecular hydrogen bonds 
along the scaffold’s rod-like backbone (Figure 16) 
 
Figure 16. Proposed conformation of self-assembled scaffold 13 
 
 
 23 
2.1 RESULTS  
2.1.1 Synthesis of Scaffold 
The synthesis of molecule 13 (Scheme 5) was achieved using standard solid phase techniques.  
The hydroxymethyl resin was chosen as the solid support because of its relatively high loading 
and facile cleavage in the presence of triflic acid (TfOH).  Naphthylalanine was first coupled to 
the resin to provide a UV chromophore to aid in monitoring the scaffold throughout 
diketopiperazine (DKP) closure and purification.  Naphthylalanine was chosen over the more 
polar tyrosine because we envisioned that it would aid in improving the solubility of the final 
product in non-polar, aprotic solvents.  The building blocks Pro4(2S,4R), Pro4(2R,4S), 
Pro4(2S,4R), Pro4(2R,4S) were then sequentially coupled to the resin.  After removal of the final 
Fmoc group in 20% piperidine in DMF, the free primary amine was acylated using 4mL of a 
100:25:2 DMF:Acetic Anhydride:DIPEA solution.  Global Boc deprotection was accomplished 
using 1:1 TFA:DCM.  Upon completion of the solid phase synthesis, the resin was dried further 
under high vacuum to ensure complete removal of residual solvents.    
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Scheme 5. Solid Phase Synthesis of Scaffold 13 
 
Cleavage of the scaffolds from the hydroxymethyl resin was achieved using standard 
triflic acid conditions.  Once the cleaved product was precipitated into ether, diketopiperazine 
formation was undertaken in NMP and promoted in the presence of 20% piperidine in NMP over 
48 h to yield the rigidified final product 13.  Preparative reverse phase HPLC purification of 13 
allowed for the isolation of the desired material in >98% purity (Figure 23).   
2.1.2 Solubility of Scaffold 
In order to study our molecule designed for self-assembly, multiple solvent systems were 
explored to identify solubility properties of the scaffold.  Ideal solvents are non-hydrogen 
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bonding solvents such as chloroform, dichloromethane, benzene.  Unfortunately molecule 13, 
was found to be insoluble in both chloroform and dichloromethane.    Using ChemDraw, an 
estimated log P value (-6.24) was obtained for 13, indicating that our molecule was extremely 
polar.  Realizing the reason for our scaffolds utter insolubility in nonpolar solvents, our efforts 
were directed to finding a more polar solvent system in which our molecule would be soluble 
while hopefully not disrupting the scaffolds ability to undergo self assembly too severely.   
In the past, our scaffolds have generally proven to be quite water-soluble.  We thought 
that if our molecule was indeed capable of self-assembly, that it would be possible to detect 
intermolecular hydrogen bonding in water, despite the interference of water on this interaction.  
However, the scaffold of interest (13) was not soluble in H2O.  Even at pH 3.5 ammonium 
acetate buffer (90% H2O:10% D2O) the scaffold was insoluble.  However, upon addition of an 
aqueous solution containing 0.2 % TFA the molecule was adequately dissolved.  It is likely that 
the addition of TFA was suppressing or destroying the very interactions we hoped to study, 
breaking apart any higher order structures, and ultimately allowing the scaffold to dissolve.  
Nonetheless, we then decided to continue the search for a solvent system that would better allow 
us explore the self-assembly of molecule 13.  Exploration of self-assembly in H2O would require 
solvent suppression NMR in order to see the chemical shifts of the amide protons.  Acetonitrile 
was an appealing solvent due to its polarity and it’s poor capability for the formation of hydrogen 
bonds.  However, once again, our molecule was insoluble in this solvent.  Acetone and methanol 
were also explored, however both solvents failed to dissolve our scaffold.  It was later 
determined that molecule 13 was soluble in DMSO.   
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2.1.3 Variable Temperature NMR Experiments 
Our first attempt to detect intermolecular hydrogen bonds between individual scaffolds 
was designed around a variable temperature NMR experiment.  We hoped to see if any notable, 
nonlinear changes in chemical shift of the scaffold’s amide protons would occur upon heating.  
Initially, our experiment was performed with scaffold concentrations of 13 mM in DMSOd6 
containing 0.2% TFA.  Figure 17 provides the results from this experiment.  A linear relationship 
between the amide proton chemical shifts and temperature for all five amide protons was 
observed.  As the temperature dependence of proton chemical shifts of intermolecularly 
hydrogen bonded amides should differ greatly from those amides not involved in hydrogen 
bonding, we interpreted our result as not supportive of our initial hypothesis for self-assembly in 
the selected solvent system.  The variable temperature NMR experiment was repeated at two 
different scaffold concentrations: 4mM, and 1mM.  We anticipated that if self-assembly was 
occurring, its effect on amide bond chemical shifts would demonstrate a concentration 
dependence.  Unfortunately, results from these additional experiments provided a similar linear 
relationship of chemical shifts with respect to temperature for all five nitrogen amide protons 
(Figure 18, Figure 19).  These findings did not support the hypothesis of intermolecular 
hydrogen bonding under the conditions employed.   
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Figure 17. Variable Temperature NMR Experiment (13mM) 
 
Variable Temperature NMR Experiment (4mM)
8.3
8.4
8.5
8.6
8.7
8.8
8.9
9
9.1
290 300 310 320 330 340 350 360
Temperature (K)
C
he
m
ic
al
 S
hi
ft 
(p
pm
)
Amide 1
Amide 2
Amide 4
Amide 3
Amide 5
 
Figure 18. Variable Temperature NMR Experiment (4mM) 
Variable Temperature NMR Experiment (1mM)
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Figure 19. Variable Temperature NMR Experiment (1mM) 
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2.1.4 Structural Characterization of Scaffold 
Full structural characterization of the scaffold was the next logical step to ensure that the 
molecule under study was indeed what we had set out to synthesize.  From the 2D NMR data we 
were able to discern the overall shape of our scaffold, and compare it with those structures 
predicted initially by CANDO.  Our scaffold was quite similar to the predicted structures as 
evidence by superimposing the observed COSY, HMQC, HMBC, and ROESY correlations onto 
the energy minimized conformation generated by MOE (Figure 21).  Structural characterization 
was completed at a substrate concentration of 13mM in DMSOd6 containing 0.2% TFA.  The 2D 
NMR spectra were assigned using the graphical NMR assignment and integration program 
SPARKY.  The NMR data confirmed the expected connectivity and stereochemistry of the 
scaffold (Figure 21).   
 
Figure 20.  Nomenclature for Structural Characterization 
 
The next section does not attempt to explain every correlation from each NMR 
experiment as that would be tedious to read and understand.  The following is only intended to 
serve as an example of how many of the assignments were made.  
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From the COSY experiment, each alpha proton was coupled to the corresponding beta 
protons.  (See Figure 16 for nomenclature of the scaffold).  The HMQC correlated protons to the 
carbon atoms they were attached.  The HMBC correlated long range couplings between (two and 
three bonds) proton to carbon atoms allowing for assignments within each Pro4 ring to be made.  
For example, the carbon atom at the beta position was correlated to the alpha proton and the 
carbon atom at the gamma position was correlated to the beta proton.  Two valuable assignments 
from the HMBC were the observed correlations between the ester carbonyl of the fifth residue to 
the isolated methyl group, and a correlation between the carbonyl of the acetyl moiety of the fifth 
residue to its neighboring methyl protons.  These protons were easily differentiated from other 
protons in the scaffold by their 1H NMR integrals, and were easily differentiated from one 
another through differences in their observed chemical shifts.  The ester protons were shifted 
downfield at ~3.5 ppm compared to the acetamide which resonates at ~1.8 ppm.  Once these 
assignments were made, it allowed other assignments from the HMBC to follow.    
Working from the other end of the molecule, the carbonyl of the carboxylic acid was 
assigned through HMBC correlation with the alpha and beta protons of the naphthylalanine 
(first) residue.  Also the chemical shift of the carbonyl (farthest downfield) supported the 
assignment.  Other important assignments within the proline rings were correlations between the 
alpha carbon to the amide of the previous residue (across DKP).  For example, the alpha carbon 
of the third residue was correlated to the amide proton of the second residue.  Amide protons 
were also correlated to both carbonyl carbons of the DKPs.    
For spatial assignment, the ROESY data was able to correlate neighboring protons 
residing on the same face of the scaffold (pseudo axial vs. pseudo equatorial).  For example, the 
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alpha protons are coupled through space to only one beta and one delta proton, as these protons 
reside are the same face of the proline ring.    
2.1.5 ROESY Data  
Correlations between protons were differentiated by peak intensity.  Intensities were 
classified as strong (red), medium (green), and weak (blue).  From the NMR analysis we were 
certain that the connectivity of our molecule was indeed as we expected it to be and that the rod-
like shape that we initially proposed was indeed present.  A key correlation (not shown) was 
2HB1 to 3NH which provides further evidence of the rod-like backbone.  If self-assembly was 
indeed occurring within our scaffold through the proposed pair of amide bonds, then we expect 
to observe ROESY correlations between an amide proton and a remote proton that could only 
arise through intermolecular hydrogen bonding. Unfortunately, ROESY analysis failed to 
produce any signals of this type, consistent with the absence of self assembled networks in 
solution.  
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Figure 21. ROESY correlations superimposed onto the energy minimized structure 
 
Under the initial conditions employed, we were not able to produce any evidence that 
suggested our system was behaving as it was originally designed.  We then turned our efforts 
towards a competitive solvent experiment.  Our thought was that by titrating a non-polar solvent 
into our sample would effect a change to the overall polarity of the system and would hopefully 
facilitate the formation of intermolecular, hydrogen-bonded networks.  We were curious to see 
what we would observe in the amide proton chemical shifts as the solvent environment would 
become more and more nonpolar.  DCMd2 was titrated to an original solution of 5.6 mM of  our 
sample dissolved in 20% DCMd2 in DMSOd6.  A 1H NMR was taken after each addition of 
DCMd2 (decrease concentration by 0.1 mM – 0.3 mM) and the amide proton chemical shifts 
were observed.  Our scaffold remained soluble even at 0.7mM in 90% DCMd2 in DMSOd6.  
Although the amide chemical shifts were changing upon addition of DCM, the trend was not 
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obvious.  The amide protons on the C-terminus and N-terminus residues were changing more 
rapidly than those on the interior of the molecule, possibly suggesting that our molecule was not 
assembling as it was initially designed, but that the exterior residues were promoting aggregation 
under the experimental conditions.  The NMR sample was left overnight at 0.7mM in 90% 
DCMd2 in DMSOd6  and molecule 13 precipitated.  A 1H NMR was taken of the sample with 
precipitate and its chemical shifts were identical to the previous sample without precipitate.  This 
suggested that the need for additional data points at higher concentration of DCMd2 were 
unnecessary.  
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Figure 22. Competitive Solvent Experiment 
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2.2 CONCLUSION  
Scaffold 13 (napthylalanine-Pro4(2S4R)-Pro4(2R4S)-Pro4(2S4R)-Pro4(2R4S)) was successfully 
synthesized using standard Fmoc Solid Phase Peptide Synthesis.  Full structural characterization 
(1H NMR, COSY, HMQC, HMBC, ROESY) confirmed desired connectivity.  Scaffold 13 was 
probed for its ability to self-assemble in DMSOd6 in the presence of 0.2 % TFA (13 mM – 4 
mM).  Scaffold 13 did not support our hypothesis for self-assembly under any of the conditions 
explored.  ROESY correlations failed to indicate self-assembly between interacting scaffolds and 
a variable temperature (25 to 80 °C) NMR study at three separate concentrations (13 mM, 4mM, 
1 mM) also failed to produce results to support the notion of self-assembly.   
The sequence selected was based on models generated from CANDO.  Perhaps the 
driving force for self-assembly in our molecule was too strong and led to the scaffolds utterly 
insolubility in non-polar solvents.  It is possible that the actual solution structure of the scaffold 
precluded its ability to self-assemble.  As we continue to gather structural knowledge about our 
scaffolds, while iteratively improving our modeling techniques, a sequence better suited for self-
assembly may emerge.  Additional building blocks from our toolbox may need to be 
incorporated into the sequence of interest, especially an emerging, functionalized building block 
that could potentially allow for additional side chain interactions.  It may be possible that the 
sequence selected did not provide a large enough driving force, enough hydrogen bonds between 
the scaffolds, to facilitate self assembly; or perhaps unforeseen steric or electronic factors were 
working against us.  A longer sequence would increase the number of hydrogen bonds between 
the scaffolds and may in turn provide the appropriate driving force for the scaffold to self-
assembly.   
  
 34 
 
 
2.3 EXPERIMENTAL  
2.3.1 General Procedure 
HPLC-MS analysis was performed on a Hewlett-Packard Series 1050 instrument with diode 
array detector, Agilent 1100 series LC-MSD SL detector (ES ion source) using a Waters XTerra 
MS C18 column (3.5 μm packing, 4.6 mm x 100 mm).  Preparative HPLC was performed on a 
Varian ProStar 500 HPLC instrument with a Waters XTerra Prep MS C18 column (5 μm packing, 
30 mm x 100 mm).  NMR experiments were performed on either a 500 MHz or 600 MHz Bruker 
instrument.  The spectrum was referenced to DMSO-d6 at δH 2.49 and δC 39.5.  
Solid phase synthesis was carried out manually using a setup constructed from standard 
laboratory materials.  Dichloromethane (CH2Cl2) was distilled from CaH2 under nitrogen.  
Anhydrous Dimethylformamide (DMF) was purchased from Aldrich.  Diisopropylethylamine 
(DIPEA) was distilled under nitrogen sequentially from ninhydrin and potassium hydroxide and 
stored over 4 Ǻ molecular sieves.  Fmoc deprotections were determined quantitatively by 
measuring the absorbance of the dibenzofulvene-piperidine adduct (λmax = 301 nm, ε = 7800 M-1 
cm-1).  (S)-N-Fmoc-1-Naphthylalanine (95%, 98% ee) was purchased from Acros and 
Hydroxylmethyl polystyrene (100-200 mesh 1% divinylbenzene (DVB) resin was purchased 
from Novabiochem.  MSNT (1-(Mesitylene-2-sulfonyl)-3-nitro-1H-1,2,4-triazole) was 
purchased from Acros.   Pro-4 monomers were synthesized in house according to published 
procedures23, 24.  
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2.3.2 Synthesis of Scaffold  
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Coupling (S)-N-Fmoc-1-Naphthylalanine:  50.0 mg Hydroxymethyl resin cross linked with 1% 
DVB was swollen in DCM for 30 min under an argon atmosphere.  Methyl imidazole (MeIm) 
(20.6 μL, 184 μmole, 3.75 eq.) was added to a 0.2 M solution of (S)-N-Fmoc-1-Naphthylalanine 
(107 mg, 245 μmole, 5 eq.) in dry DCM.  To this solution was added to MSNT (73 mg, 245 
μmole, 5 eq.) and the mixture was allowed to preactivate for 10 min.  The coupling solution was 
added to the resin and agitated under argon for 1 h.  Unreacted resin was capped with two 
successive 4 mL treatments of a 100:25:2 solution of DMF, acetic anhydride, DIPEA for 10 min.  
The capping solution was drained and the resin was rinsed repeatedly with DMF to remove 
excess reagents.  Fmoc deprotection was achieved by treatment for 30 min with 3 mL of a 20% 
solution of piperdine in DMF.  The progress of the Fmoc deprotection was quantified by 
aliquoting 10 μL of the 20% piperidine DMF solution bathing the resin beads and diluting to 
1mL with an additional quantity of  20% piperidine in DMF.  The deprotecting solution was 
drained and the resin was washed with DMF (2 mL), IPA (2 mL), DMF (2 mL). The resin was 
then swollen in DMF for 10 min.  
Coupling Fmoc-Pro4(2S,4R):  DIPEA (34.1 μL, 196 μmole, 4 eq.) was added to a 0.2 M 
solution of Fmoc-Pro4(2S, 4R) (50 mg, 98 μmole, 2 eq.) in dry DCM in DMF with HATU (37.3 
mg, 98 μmole, 2 eq.).  This solution was allowed to preactivate for 10 min.  The coupling 
solution was then added to the resin and agitated under argon for 30 min. A second coupling of 
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Fmoc-Pro 4 (2S, 4R) was repeated using above procedure.  Unreacted resin was capped with two 
successive 4 mL treatments of a 400:100:8 solution of DMF, acetic anhydride, DIPEA for 10 
min.  The capping solution was drained and the resin was rinsed repeatedly with DMF to remove 
excess reagents.  Fmoc deprotection was achieved by treatment for 30 min with 3 mL of a 20% 
solution of piperdine in DMF.  The progress of the Fmoc deprotection was quantified by 
aliquoting 10 μL of the 20% piperidine DMF solution bathing the resin beads and diluting to 
1mL with an additional quantity of  20% piperidine in DMF.  The deprotecting solution was 
drained and the resin was washed with DMF (2 mL), IPA (2 mL), DMF (2 mL). The resin was 
then swollen in DMF for 10 min.  
Coupling Fmoc-Pro4(2R, 4S): DIPEA (34.1 μL, 196 μmole, 4 eq.) was added to a 0.2 M 
solution of Fmoc-Pro 4 (2R, 4S) (50 mg, 98 μmole, 2 eq.) in dry DCM in DMF with HATU (37.3 
mg, 98 μmole, 2 eq.).  This solution was allowed to preactivate for 10 min.  The coupling 
solution was then added to the resin and agitated under argon for 30 min. A second coupling of 
Fmoc-Pro 4 (2R, 4S) was repeated using above procedure.  Unreacted resin was capped with two 
successive 4 mL treatments of a 400:100:8 solution of DMF, acetic anhydride, DIPEA for 10 
min.  The capping solution was drained and the resin was rinsed repeatedly with DMF to remove 
excess reagents.  Fmoc deprotection was achieved by treatment for 30 min with 3 mL of a 20% 
solution of piperdine in DMF.  The progress of the Fmoc deprotection was quantified by 
aliquoting 10 μL of the 20% piperidine DMF solution bathing the resin beads and diluting to 
1mL with an additional quantity of  20% piperidine in DMF.  The deprotecting solution was 
drained and the resin was washed with DMF (2 mL), IPA (2 mL), DMF (2 mL). The resin was 
then swollen in DMF for 10 min.  
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Coupling Fmoc-Pro4(2S, 4R):  DIPEA (34.1 μL, 196 μmole, 4 eq.) was added to a 0.2 
M solution of Fmoc-Pro 4 (2SR, 4RS) (50 mg, 98 μmole, 2 eq.) in dry DCM in DMF with HATU 
(37.3 mg, 98 μmole, 2 eq.).  This solution was allowed to preactivate for 10 min.  The coupling 
solution was then added to the resin and agitated under argon for 30 min. A second coupling of 
Fmoc-Pro 4 (2S, 4R) was repeated using above procedure.  Unreacted resin was capped with two 
successive 4 mL treatments of a 400:100:8 solution of DMF, acetic anhydride, DIPEA for 10 
min.  The capping solution was drained and the resin was rinsed repeatedly with DMF to remove 
excess reagents.  Fmoc deprotection was achieved by treatment for 30 min with 3 mL of a 20% 
solution of piperdine in DMF.  The progress of the Fmoc deprotection was quantified by 
aliquoting 10 μL of the 20% piperidine DMF solution bathing the resin beads and diluting to 
1mL with an additional quantity of  20% piperidine in DMF.  The deprotecting solution was 
drained and the resin was washed with DMF (2 mL), IPA (2 mL), DMF (2 mL). The resin was 
then swollen in DMF for 10 min. 
Coupling Fmoc-Pro4(2R, 4S):  DIPEA (34.1 μL, 196 μmole, 4 eq.) was added to a 0.2 
M solution of Fmoc-Pro 4 (2R, 4S) (50 mg, 98 μmole, 2 eq.) in dry DCM in DMF with HATU 
(37.3 mg, 98 μmole, 2 eq.).  This solution was allowed to preactivate for 10 min.  The coupling 
solution was then added to the resin and agitated under argon for 30 min. A second coupling of 
Fmoc-Pro 4 (2R, 4S) was repeated using above procedure. Fmoc deprotection was achieved by 
treatment for 30 min with 3 mL of a 20% solution of piperdine in DMF.  The progress of the 
Fmoc deprotection was quantified by aliquoting 10 μL of the 20% piperidine DMF solution 
bathing the resin beads and diluting to 1mL with an additional quantity of  20% piperidine in 
DMF.  The deprotecting solution was drained and the resin was washed with DMF (2 mL), IPA 
(2 mL), DMF (2 mL).  Unreacted resin was capped with two successive 4 mL treatments of a 
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400:100:8 solution of DMF, acetic aanhydride, DIPEA for 10 min.  The capping solution was 
drained and the resin was rinsed repeatedly with DMF to remove excess reagents.  Global Boc 
deprotection was achieved with two successive 2mL treatments of 1:1 solution of DCM:TFA for 
10 min. The resin was then swollen in DCM for 10 min. The solution was drained and the resin 
was rinsed with DMF (2 mL), IPA (2 mL), DMF (2 mL) alternating followed by DCM (2 mL), 
IPA (2mL), DCM (2 mL) alternating and then swelled in DCM for 5 min.  Scaffold was placed 
under high vacuum overnight to removal residual solvents. 
2.3.3 Cleavage from Resin 
Ethanedithiol (EDT) (12.5 μL, 0. 149 mmol) and thioanisole (25 μL, 0. 213 mmol) was 
added to the resin reactor.  The reactor was chilled to 0 ◦C using an ice bath and then 
trifluoroacetic acid (TFA) (250 μL, 3.35 mmol) was added and the mixture was allowed to stir 
for an additional 5 min at 0 ◦C.  Trifluoromethanesulfonic acid (TFMSA) (25 μL, 0.282 mmol) 
was added and the solution was vigorously stirred for 1 hour at 0 ◦C, followed by an additional 1 
h at room temperature.  The acidic cleavage solution was drained into 5 mL diethylether. The 
resin was washed with 3 * 500 μL TFA and the washes were drained into the diethylether 
solution.  The collected material was centrifuged and the solution was decanted leaving a white 
precipitate.  The precipitate was dissolved in 2 mL of a solution containing 74.5%  H20, 25% 
ACN, and 0.5 % Formic Acid.  The sample was subjected to HPLC-MS analysis to check for 
purity and mass. The sample was eluted from the column using a gradient of 0-50% ACN in H2O 
containing 1% Formic Acid over 30 min.  The analysis indicated that the isolated material (tr 
12.36 min) was roughly 73 % pure and provided an ion at 937.4 (M + H+), 469.4 (M + 2H+), 
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313.4 (M + 3H+) m/z consistent with the presence of the desired product. Sample was 
lyophilized to afford a white powder.   
2.3.4 Diketopiperazine Closure 
Cleavage product was subjected to 1 mL of dry 20% piperidine in NMP (N-
methylpyrrolidone).  After 1.5 days the reaction solution was precipitated into cold ether (10 
mL). The collected material was centrifuged and the solution was decanted leaving a white 
precipitate.  The precipitate was dissolved in  74.5%  H20, 25% ACN, and 0.5 % Formic Acid.   
The sample was subjected to HPLC-MS analysis to check for purity and mass. The sample was 
eluted from the column using a gradient of 0-50% ACN in H2O containing 1% Formic Acid over 
30 min.  The analysis indicated that the isolated material (tr 17.06 min) was roughly 72 % pure 
and provided an ion at 842.1 (M + H+), 421.6 (M + 2H+) m/z consistent with the presence of the 
desired product.  
2.3.5 Preparative Purification 
Preparative purification of the rigidified product was accomplished using a gradient of 0-
50% ACN in H2O containing 1% Formic Acid over 30 min.  Fractions containing the desired 
product were combined and lyophilized to afford a white powder.  The purified product was 
dissolved in 4 mL 74.5%  H20, 25% ACN, and 0.5 % Formic Acid (Figure 23).  Product 
concentration was calculated based upon UV absorbance at 274 nm using a calibration curve of 
1-naphthylalanine.   
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2.3.6 NMR Sample Preparation 
(13 mM): The NMR sample of 13 was prepared by dissolving 4.8 μmole of 13 in 369 μL 
DMSOd6 with 0.2% TFA and transferred to a Shigemi NMR tube to afford a 13mM sample. The 
chemical shift assignments are based upon COSY, HMQC, HMBC, and ROESY correlations. 
Sparky was used to assign and integrate the 2D spectra.  
(4mM): The NMR sample of compound  13 that was used for structural determination 
(13 mM in DMSO-d6 with 0.2% TFA) was diluted with 1mL 74.5%  H2O, 25% ACN, and 0.5 % 
Formic Acid, and purified by preparative HPLC.  Prep purification of samples was accomplished 
using a 0-50% ACN in H2O containing 1% Formic Acid over 30 min.  Fractions containing the 
desired product were combined and lyophilized to afford a white powder.  Product was dissolved 
in 4 mL 74.5%  H20, 25% ACN, and 0.5 % Formic Acid.  Product concentration was calculated 
based upon UV absorbance at 274 nm using a calibration curve of 1-naphthylalanine.  HPLC-MS 
was used to check for purity and mass using a 30 min 0% ACN to 50% ACN with H2O and 1% 
Formic Acid.  Sample was freeze dried to afford a white powder.  1.5μ L TFA was added to 750 
uL DMSOd6.   Compound 13 was dissolved in 380 μL DMSOd6 with 0.2% TFA and transferred 
to a Shigemi NMR tube to afford a 4mM sample.  
(1mM): The 4mM sample of compound 13 was diluted using 0.2% TFA in 752 μL 
DMSOd6 to afford a 1mM sample.  
Competitive Solvent Experiment:  The NMR sample of # was prepared by dissolving 
2.1 μmole 13 in 300 μL DMSOd6 with 0.2% TFA and transferred to a Shigemi NMR tube and 
then added 75 μL DCMd2 to afford a 5.6 mM sample.  Each subsequent NMR sample was 
prepared by titrating in the desired amount of  DCMd2Table 1.  
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Table 1.  Competitive Titration Experiment 
  
Total Volume 
(uL) 
Volume DCM 
(uL) 
DCM Added 
(uL) 
Volume DMSO 
(uL) % DCM mM 
1 375 75 - 300 20.0 5.6 
2 400 100 25 300 25.0 5.3 
3 425 125 25 300 29.4 5.0 
4 450 150 25 300 33.3 4.7 
5 475 175 25 300 36.8 4.4 
6 500 200 25 300 40.0 4.2 
7 525 225 25 300 42.9 4.0 
8 550 250 25 300 45.5 3.8 
9 575 275 25 300 47.8 3.7 
10 600 300 25 300 50.0 3.5 
11 650 350 50 300 53.8 3.2 
12 700 400 50 300 57.1 3.0 
13 750 450 50 300 60.0 2.8 
14 800 500 50 300 62.5 2.6 
15 875 575 75 300 65.7 2.4 
16 950 650 75 300 68.4 2.2 
17 1050 750 100 300 71.4 2.0 
19 1150 850 100 300 73.9 1.8 
20 1300 1000 150 300 76.9 1.6 
21 1500 1200 200 300 80.0 1.4 
22 1700 1400 200 300 82.4 1.2 
23 2100 1800 400 300 85.7 1.0 
24 2600 2300 500 300 88.5 0.8 
25 3000 2700 400 300 90.0 0.7 
26 3000 2700 400 300 90 0.7 
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APPENDIX A 
SUPPLEMENTAL DATA 
A.1 HPLC DATA 
 
Figure 23. HPLC-MS of Scaffold: mobile phase, H2O (0.1 % HCOOH) to 50% MeCN (0.05% HCOOH) and 
50% H2O (0.1 % HCOOH over 30 min; flow rate 0.80 mL/min; UV detection at 274 nm; tr for compound 13, 
17.02 min; ESI-MS m/z (ion): 842.2 (M + H+), 421.8 (M + 2H+). 
 
 
 43 
A.2 2 D NMR DATA 
 
Nomenclature in the 2D-NMR data tables: 
Residue: the number corresponds to the placement of the residue within the scaffold starting with 
1 which corresponds to the C-terminus (napthylalanine)  
Atom: refers to the nucleus (C or H) whose chemical shift and correlation is being observed 
 
Position:  refers to the location of the nucleus of interest  
 A = alpha 
 B = beta 
 G = gamma 
 D = delta 
 N = amide nitrogen 
 GC = carbonyl carbon adjacent to gamma carbon 
 CAC = carbonyl carbon adjacent to alpha carbon  
 C# = carbon off residue 1 
 H# = hydrogen off residue 1 
 COE = carbonyl carbon adjacent to the methyl ester 
 CNC = carbonyl carbon of the acetamide moiety  
 CAM = carbon of the methyl protons 
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Table 2.  Resonance Assignments for Scaffold 
Group Position Atom Chemical Shift Std Dev Assignments 
1 C1 13C 131.201 0.027 4 
1 C10 13C 127.458 0.254 3 
1 C2 13C 133.642 0.000 0 
1 C3 13C 123.153 0.299 3 
1 C4 13C 126.066 0.000 1 
1 C5 13C 125.463 0.000 1 
1 C6 13C 128.374 0.000 1 
1 C7 13C 133.642 0.072 3 
1 C8 13C 127.341 0.000 1 
1 C9 13C 125.032 0.000 1 
1 CA 13C 53.178 0.000 4 
1 CAC 13C 172.326 0.048 3 
1 CB 13C 33.855 0.030 6 
1 H10 1H 7.405 0.161 17 
1 H3 1H 8.132 0.004 16 
1 H4 1H 7.613 0.005 7 
1 H5 1H 7.545 0.002 8 
1 H6 1H 7.949 0.003 10 
1 H7 1H 7.842 0.008 11 
1 H8 1H 7.444 0.007 5 
1 HA 1H 4.639 0004 16 
1 HB1 1H 3.667 0.003 17 
1 HB2 1H 3.272 0.004 18 
1 HN 1H 9.029 0.002 16 
2 CA 13C 58.829 0.135 2 
2 CAC 13C 166.329 0.005 2 
2 CB 13C 41.620 0.133 4 
2 CD 13C 52.022 0.165 4 
2 CG 13C 64.939 0.015 4 
2 CGC 13C 63.005 0.032 3 
2 HA 1H 4.355 0.002 2 
2 HB1 1H 2.744 0.003 12 
2 HB2 1H 1.953 0.002 14 
2 HD1 1H 3.353 0.001 12 
2 HD2 1H 4.092 0.002 6 
2 HN 1H 8.948 0.004 4 
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3 CA 13C 57.248 0.119 12 
3 CAC 13C 167.534 0.162 3 
3 CB 13C 39.920 0.079 4 
3 CD 13C 53.836 0.046 2 
3 CG 13C 62.421 0.059 3 
3 CGC 13C 164.116 0.185 3 
3 HA 1H 4.528 0.005 14 
3 HB1 1H 2.603 0.005 10 
3 HB2 1H 2.134 0.005 9 
3 HD1 1H 3.479 0.004 6 
3 HD2 1H 4.233 0.007 3 
3 HN 1H 8.838 0.004 12 
4 CA 13C 57.144 0.099 3 
4 CAC 13C 168.068 0.005 3 
4 CB 13C 39.911 0.084 4 
4 CD 13C 53.856 0.043 2 
4 CG 13C 62.325 0.002 2 
4 CGC 13C 164.492 0.157 3 
4 HA 1H 4.623 0.005 12 
4 HB1 1H 2.567 0.004 10 
4 HB2 1H 2.166 0.008 9 
4 HD1 1H 3.447 0.001 5 
4 HD2 1H 4.223 0.003 2 
4 HN 1H 8.919 0.001 12 
5 CA 13C 56.675 0.147 5 
5 CAC 13C 168.078 0.042 4 
5 CB 13C 36.989 0.266 6 
5 CD 13C 53.789 0.038 3 
5 CG 13C 60.670 0.030 5 
5 CGC 13C 171.425 0.144 5 
5 COE 13C 52.352 0.013 2 
5 HA 1H 4.638 0.003 11 
5 HB1 1H 2.493 0.005 12 
5 HB2 1H 2.415 0.005 12 
5 HD1 1H 3.493 0.004 8 
5 HD2 1H 4.097 0.003 9 
5 HE1 1H 3.583 0.002 4 
5 HN 1H 8.749 0.004 15 
6 CAM 13C 22.120 0.182 2 
6 CNC 13C 170.053 0.034 2 
6 HM1 13C 1.851 0.002 6 
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Figure 24.  COSY correlations superimposed on the energy minimized structure 
 
Figure 25.  HMBC correlations superimposed on the energy minimized  
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Figure 26.  COSY  
 
Figure 27.  COSY 
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Figure 28.  HMQC 
 
 
Figure 29.  HMQC 
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Figure 30.  HMBC 
 
 
Figure 31.  HMBC 
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Figure 32.  HMBC 
 
 
Figure 33.  HMBC 
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Figure 34.  ROESY 
 
 
 
Figure 35.  ROESY 
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Figure 36.  ROESY 
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